Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics

[News]

Celldex Therapeutics, Inc. today announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers.

More... (http://www.news-medical.net/news/20091213/Positive-Phase-2-study-results-of-CDX-011-reported-by-Celldex-Therapeutics.aspx)